IRHYTHM TECHNOLOGIES, INC.
IRTC US4500561067
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-48% | -22% | 14% | -11% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Wilson Daniel G. CFO |
175.00 USD |
5,000 Sold |
875,000 USD |
03/09/2025 | 03/09/2025 |
Wilson Daniel G. CFO |
167.28 USD |
737 Sold |
123,285 USD |
02/09/2025 | 02/09/2025 |
Shrishrimal Sumi EX VP |
167.12 USD |
653 Sold |
109,129 USD |
22/08/2025 | 22/08/2025 |
Talwalkar Abhijit Y |
157.57 USD |
3,183 Sold |
501,553 USD |
11/08/2025 | 11/08/2025 |
Talwalkar Abhijit Y |
158.68 USD |
2,129 Sold |
337,828 USD |
11/08/2025 | 11/08/2025 |
Rosenbaum Marc Wade CCO |
158.93 USD |
226 Sold |
35,918 USD |
11/08/2025 | 11/08/2025 |
Patterson Chad CCO |
158.97 USD |
2,555 Sold |
406,168 USD |
06/08/2025 | 06/08/2025 |
Blackford Quentin S. CEO |
160.73 USD |
4,905 Sold |
788,361 USD |
05/08/2025 | 05/08/2025 |
Blackford Quentin S. CEO |
158.85 USD |
8,726 Sold |
1,386,157 USD |
05/08/2025 | 05/08/2025 |
Blackford Quentin S. CEO |
165.00 USD |
306 Sold |
50,490 USD |
05/08/2025 | 05/08/2025 |